Skip to main content
Premium Trial:

Request an Annual Quote

Genomica Prices IPO, Hopes to raise $122M

NEW YORK, Sept 29 – Bioinformatics company Genomica (Nasdaq: GNOM) said Friday it had priced its initial public offering of 6,440,000 shares of common stock on the Nasdaq at $19.00 per share.

Gross proceeds from the offering, the latest in a string of bioinformatics IPOs, are expected to be $122.4 million.

CIBC World Markets was the lead manager for the offering. Dain Rauscher Wessels and Prudential Vector Healthcare Group were co-managers.

The Company has granted the underwriters a 30-day option to purchase up to 966,000 additional shares of common stock to cover any over-allotments in connection with the offering.

Genomica of Boulder, Colo., develops software products and services for pharmaceutical and biotechnology researchers that are designed to accelerate the drug discovery and development process.

Last month Applied Biosystems (NYSE: PEB) agreed to make a $3 million equity investment in the company. As part of that deal the companies also signed an agreement under which Genomica will license its genetic-analysis object model to Applied Biosystems.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.